{"id":53413,"date":"2023-01-30T15:02:26","date_gmt":"2023-01-30T14:02:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/"},"modified":"2023-01-30T15:02:26","modified_gmt":"2023-01-30T14:02:26","slug":"vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/","title":{"rendered":"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023"},"content":{"rendered":"
\n

WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on Monday, February 13, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.\n<\/p>\n

<\/a><\/p>\n

\nInvestors interested in listening to the conference call may do so by dialing + 1 (646) 904 5544 for domestic callers or + 1 (929) 526 1599 for international callers, using access code: 310939 . A live and archived webcast of the event will be available at https:\/\/investor.vicarioussurgical.com<\/a>.\n<\/p>\n

\nAbout Vicarious Surgical<\/b>\n<\/p>\n

\nFounded in 2014, Vicarious Surgical is a next generation surgical robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company\u2019s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla\u2019s Khosla Ventures, Innovation Endeavors, Jerry Yang\u2019s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang\u2019s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact<\/b>
Kaitlyn Brosco
\n
Vicarious Surgical
\n
Kbrosco@vicarioussurgical.com<\/a>\n<\/p>\n

\nMarissa Bych
\n
Gilmartin Group
\n
Marissa@gilmartinir.com<\/a>\n<\/p>\n

\nMedia Inquiries<\/b>
Abby Mayo for Matter Health
\n
media@vicarioussurgical.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on Monday, February 13, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53413","6":"format-standard","7":"category-industry"},"yoast_head":"\nVicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on Monday, February 13, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-30T14:02:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230130005062\/en\/1698417\/21\/download.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023\",\"datePublished\":\"2023-01-30T14:02:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/\"},\"wordCount\":270,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005062\\\/en\\\/1698417\\\/21\\\/download.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/\",\"name\":\"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005062\\\/en\\\/1698417\\\/21\\\/download.jpg\",\"datePublished\":\"2023-01-30T14:02:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005062\\\/en\\\/1698417\\\/21\\\/download.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005062\\\/en\\\/1698417\\\/21\\\/download.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/","og_locale":"en_US","og_type":"article","og_title":"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023 - Pharma Trend","og_description":"WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on Monday, February 13, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-30T14:02:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230130005062\/en\/1698417\/21\/download.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023","datePublished":"2023-01-30T14:02:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/"},"wordCount":270,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230130005062\/en\/1698417\/21\/download.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/","url":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/","name":"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230130005062\/en\/1698417\/21\/download.jpg","datePublished":"2023-01-30T14:02:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230130005062\/en\/1698417\/21\/download.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230130005062\/en\/1698417\/21\/download.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-13-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53413"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53413\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}